Viggo Jønsson

Image of Viggo Jønsson
Norwegian version of this page
Username
Visiting address Sognsvannsveien 20 OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publications

  • Jønsson, Viggo; Awan, Haneef; Jones, Neil Deaton; Johannessen, Tom Børge; Thøgersen, Klaus & Steig, Bjarni á [Show all 8 contributors for this article] (2022). Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders. Scientific Reports. ISSN 2045-2322. 12:6138(1), p. 1–11. doi: 10.1038/s41598-022-09602-1. Full text in Research Archive
  • Jønsson, Viggo; Awan, Haneef; Jones, Neil D.; Johannessen, Tom Børge; Steig, Bjarni A & Andosdottir, Gudrid [Show all 7 contributors for this article] (2019). Inheritance of Susceptibility to Malignant Blood Disorders. Scientific Reports. ISSN 2045-2322. 9, p. 1–12. doi: 10.1038/s41598-019-38879-y. Full text in Research Archive
  • Awan, Haneef; Furuholmen, Johanna; Tjønnfjord, Geir Erland; Ly, Bernt; Johannesen, Tom Børge & Tierens, Anne [Show all 8 contributors for this article] (2014). Segregation of Malignant Hematological Disease in Families with Malignant Lymphoma. Journal of genetic syndrome & gene therapy. ISSN 2157-7412. 5(6).
  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom Børge & Tjønnfjord, Geir Erland (2014). Chronic Lymphocytic Leukemia, Advantages of Monoclones? Journal of Leukemia. ISSN 2329-6917. 2(3).
  • Mulligan, Stephen; Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Gill, Devinder S. & Hammerstrøm, Jens [Show all 16 contributors for this article] (2014). Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia. Leukemia and Lymphoma. ISSN 1042-8194. 55(12), p. 2769–2777. doi: 10.3109/10428194.2014.893306.
  • Tjønnfjord, Geir Erland; Jønsson, Viggo; Ly, Bernt Erik & Johannessen, Tom Børge (2012). Familiær forekomst av kronisk lymfatisk leukemi i Norge. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 132(18), p. 2060–2063. doi: 10.4045/tidsskr.11.1350.
  • Tjønnfjord, Geir Erland; Ly, Bernt Erik; Johannesen, Tom Børge; Tierens, Anne; Beiske, Klaus & Heim, Sverre [Show all 7 contributors for this article] (2012). Kronisk lymfatisk leukemi i Norge – insidens og prognose ved diagnosetidspunktet. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 132(18), p. 2056–2059. doi: 10.4045/tidsskr.11.1349.
  • Jønsson, Viggo; Awan, Haneef; Nyquist, Emil; Maisenhölder, Martin; Johannesen, Tom Børge & Ly, Bernt Erik [Show all 7 contributors for this article] (2011). Familial Hodgkin's Lymphoma in Scandinavia. In Vivo. ISSN 0258-851X. 25(3), p. 431–437.
  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom B.; Ly, Bernt & Tjønnfjord, Geir Erland (2010). Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders. Translational Oncogenomics. ISSN 1177-2727. 4, p. 1–9.
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Johannesen, Tom Børge; Ly, Bernt Erik; Olsen, Jørgen H & Yuille, Martin (2010). Familial Chronic Lymphocytic Leukemia in Norway and Denmark. Comments on Pleiotropy and Birth Order. In Vivo. ISSN 0258-851X. 24(1), p. 85–95.
  • Crowther-Swanepoel, D; Wild, R; Sellick, G; Dyer, MJS; Mauro, FR & Cuthbert, RJG [Show all 13 contributors for this article] (2008). Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL. Blood. ISSN 0006-4971. 111, p. 5691–5693. doi: 10.1182/blood-2008-03-142349.
  • Olsen, AL; Johannesen, TB; Ly, Bernt Erik; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & Jønsson, Viggo (2008). Pleiotropy in families with chronic lymphocytic leukemia. Salud (i) Ciencia. ISSN 1667-8982. 15, p. 1236–+.
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Johannesen, T.B.; Samuelsen, Sven Ove & Ly, Bernt Erik (2008). Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders. Translational Oncogenomics. ISSN 1177-2727. 3, p. 1–6.
  • Jønsson, Viggo; Hasselbalch, Hans & Christensen, Bjarne Egelund (2007). Jern, B-vitaminer og medikamentel knoglemarvspåvirkning. In Kampmann, Jens P.; Brøsen, Kim & Simonsen, Ulf (Ed.), Basal og klinisk farmakologi. FADL's Forlag a/s. ISSN 978-87-7749-382-9. p. 655–64.
  • Jønsson, Viggo; Hasselbalch, Hans & Christensen, Bjarne Egelund (2007). Blodsygdomme. In Schroeder, Torben V.; Schulze, Svend; Hilsted, Jannik & Gøtzsche, Liv (Ed.), Basisbog i Medicin & Kirurgi. Munksgaard Danmark. ISSN 978-87-628-0573-6. p. 693–736.
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Samuelsen, Sven Ove; Johannesen, Tom; Olsen, Jørgen & Sellick, Gabrielle [Show all 9 contributors for this article] (2007). Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease. Leukemia and Lymphoma. ISSN 1042-8194. 48(12), p. 2387–2396. doi: 10.1080/10428190701686273.
  • Jønsson, Viggo & Olsen, Jørgen H (2006). Arv og lymfoproliferativ sygdom. Ugeskrift for Læger. ISSN 0041-5782.
  • Lotfi, K*; Karlsson, Karin; Fyrberg, A*; Juliusson, G.; Jønsson, Viggo & Peterson, Curt [Show all 8 contributors for this article] (2006). The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. Biochemical Pharmacology. ISSN 0006-2952.
  • Jønsson, Viggo & Johannessen, Tom B (2006). Anticipation in lymphoproliferative disorders. Leukemia and Lymphoma. ISSN 1042-8194. 47(10), p. 2015–2016.
  • Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS & Jønsson, Viggo [Show all 15 contributors for this article] (2005). A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. American Journal of Human Genetics. ISSN 0002-9297. 77, p. 420–429.
  • Jønsson, Viggo; Houlston, RS; Catovsky, D; Yuille, M; Hilden, J. & Olsen, J.H. [Show all 11 contributors for this article] (2005). CLL family 'Pedigree 14' revisitet: 1947-2004. Leukemia. ISSN 0887-6924. 19(6), p. 1025–8.
  • Egelund Christensen, Bjarne & Jønsson, Viggo (2004). Blodsygdomme. In Schroeder, Torben V.; Schulze, Svend; Hilsted, Jannik & Aldershvile, Jan (Ed.), Basisbog i medicin og kirurgi. Munksgaard Forlag. ISSN 87-628-0402-2. p. 727–767.
  • Jønsson, Viggo & Egelund Christensen, Bjarne (2004). Maligne hæmatologiske sygdomme. In Ringborg, Ulrik; Henriksson, Roger & Friberg, Sten (Ed.), Kræftsygdomme � onkologi. Fadl's forlag. ISSN 87-7749-317-6. p. 392–411.
  • Gniadecki, R.; Rossen, K.; Ralfkier, E.; Thomsen, K.; Skovgaard, G.L. & Jønsson, Viggo (2004). CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Archives of Dermatology. ISSN 0003-987X. 140(4), p. 427–36.

View all works in Cristin

  • Jønsson, Viggo; Awan, Haneef; Johannesen, Tom Børge; Ly, Bernt & Tjønnfjord, Geir Erland (2009). Birth Order Effect in the Inheritance of CLL.
  • Jønsson, Viggo (2008). Birth order effect in the inheritance of chronic lymphocytic leukemia (CLL). Anticancer Research. ISSN 0250-7005. 28(5c).
  • Kolstad, A; Tjonnfjord, G & Jønsson, Viggo (2008). High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT. Bone Marrow Transplantation. ISSN 0268-3369. 42, p. 427–428. doi: 10.1038/bmt.2008.183.
  • Johannesen, Tom Børge; Ly, Bernt Erik; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & Jønsson, Viggo (2008). Ny studie om kronisk lymfatisk leukemi i Norge. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 128(6).
  • Jønsson, Viggo; Samuelsen, Sven Ove; Tjønnfjord, Geir Erland & johannesen, tom (2008). Looking for CLL genes. Leukemia and Lymphoma. ISSN 1042-8194. 49, p. 10–11. doi: 10.1080/10428190701713705.
  • Jønsson, Viggo; Tjønnfjord, Geir Erland; Samuelsen, Sven Ove; Johannesen, Tom & Ly, Bernt (2007). Pleiotrophy in familial CLL. Leukemia and Lymphoma. ISSN 1042-8194. 48.
  • Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Mulligan, Stephen; Liliemark, Jan & Juliusson, Gunnar (2007). Improved response duration from first-line treatment with cladribine (CdA), as compared to fludarabine (F) of high-dose intermittent chlorambucil (Chl) for first-line treatment of symptomatic chronic lymphocytic leukemia (CLL). First results from the International Randomized Phase III Trial. Leukemia and Lymphoma. ISSN 1042-8194. 48, p. 167–68.
  • Jønsson, Viggo (2006). Arv og kræft. Ugeskrift for Læger. ISSN 0041-5782.
  • Karlsson, K.; Strømberg, M.; Willander, K.; Jønsson, Viggo; Hammerstrøm, J. & Uggla, B. [Show all 13 contributors for this article] (2005). IgH mutational status is of limited prognostic value in untreated symptomatic CLL patients - results from the prospective International Phase III study. Leukemia and Lymphoma. ISSN 1042-8194. 46.
  • Sellick, GS; Webb, EL; Allinson, R; Matutes, E; Dyer, MJS & Jønsson, Viggo [Show all 15 contributors for this article] (2005). A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia susceptibility loci. Leukemia and Lymphoma. ISSN 1042-8194. 46.
  • Karlsson, Karin; Strømberg, Mats; Jønsson, Viggo; Devinder, Gill; Wallvik, Jonas & Mulligan, Stephen [Show all 9 contributors for this article] (2004). Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial.

View all works in Cristin

Published Apr. 13, 2011 2:55 PM - Last modified May 27, 2011 4:13 PM